Langfang Gaobo Jingband Pharmaceutical Co., Ltd. was founded by Beijing Sihuan Pharmaceutical Co., Ltd., the wholly-owned subsidiary of the largest cardiovascular and cerebrovascular drug manufacturer in China Sihuan Pharmaceutical Holding Group (00460.HK), and Beijing Gaobo Pharmaceutical Chemical Technological Development Co., Ltd., which is sed in the production of APIs and intermediate in the year of 2009 with the registered capital of 30 million Yuan RMB. It is situated in Houyi development zone, Yongqing county, Langfang city, Hebei province, China, 60km from Beijing and Tianjin, 2km from the exit of Jingtai Expressway, it takes around 2.5 hr from the site to Beijing Airport by car. The company covers an area of 53358.9㎡ with the building area of 13000㎡. The total design capacity of reactor is 43,000 L. At present, we have 120 employees, 85% of which have college degree or above. On September 29, 2011, Chinese GMP (2010 edition) was obtained for three APIs (naloxone hydrochloride, cinepazide maleate, oxcarbazepine). In 2012, another GMP was obtained for API Nilestriol and tablets (hormones). In July, the company has been inspected by US FDA and EIR report was received on 13th May,2014. Our company is equipped with state-of-the-art pharmaceutical manufacturing facility, managed by a highly sed team of professionals and inspected by customers and regulatory agencies. We strive to become a well-known international manufacturer of APIs and intermediates . Adhering to the operation philosophy of 'cooperation and share' and win-win spirit, we would like to creat a bright future with friends at home and abroad.